๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Peripheral Blood Stem Cell Transplantation

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma NCT02605421Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Thiotepa, Cyclophosphamide, Melphalan, Etoposide, Carboplatin Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) NCT04991103Phase 21 site๐Ÿ“ Birmingham University of Alabama at Birmingham ยท Tests: DaraVRD/DaraVCD Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma NCT06245629n/a1 site๐Ÿ“ Uppsala Uppsala University ยท Tests: Bortezomib-bendamustine-melphalan Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation NCT07341698NA1 site๐Ÿ“ Copenhagen Copenhagen University Hospital, Rigshospitalet ยท Tests: Resistance training, Nutritional Support, Usual care Prehabilitation Feasibility Among Older Adults Undergoing Transplantation NCT05642884NA1 site๐Ÿ“ Birmingham Noha Mohamed Sharafeldin ยท Tests: Multi-modal Exercise Regimen, Dietary Guidelines Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation NCT06008808Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Ruxolitinib, Abatacept The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation NCT05436418Phase 1, Phase 22 sites๐Ÿ“ Duarte๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Melphalan, Sirolimus, Total Body Irradiation (TBI), Cyclophosphamide, Mycophenolate Mofeti Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea NCT06698887n/a5 sites๐Ÿ“ Hwasun๐Ÿ“ Seoul๐Ÿ“ Seoul Bristol-Myers Squibb ยท Tests: Idecabtagene vicleucel CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases NCT06787560EARLY Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: CD7 CAR-T cells injection, Allo-HSCT Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma NCT03909412Phase 11 site๐Ÿ“ Hackensack Hackensack Meridian Health ยท Tests: Carfilzomib, Cyclophosphamide, Dexamethasone, Granulocyte Colony-Stimulating Factor Helical Tomotherapy in Multiple Myeloma NCT05970198NA1 site๐Ÿ“ Wuhan Fuling Zhou ยท Tests: Total Marrow irradiation๏ผŒTMI, Autologous hematopoietic stem cell transplantation Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant NCT06856226n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Arm 1 A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies NCT03802695Phase 112 sites๐Ÿ“ Duarte๐Ÿ“ Sacramento๐Ÿ“ Stanford Orca Biosystems, Inc. ยท Tests: OrcaGraft (Orca-Q) Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT) NCT06803745NA1 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: 200 cGy or 400 cGy total body irradiation (TBI) Immune Reconstitution in Stem Cell Transplant Recipients NCT02129543n/a1 site๐Ÿ“ Miami University of Miami ยท Tests: Blood Draw High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) NCT07205523n/a1 site๐Ÿ“ Xining Yigeng Cao,MD,PhD Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) NCT03970096Phase 23 sites๐Ÿ“ Tampa๐Ÿ“ Pittsburgh๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Total-Body Irradiation, Thiotepa, Fludarabine, Tacrolimus, Allogeneic CD34+-enriched and CD45RA-depleted PBSCs The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen NCT01890486n/a1 site๐Ÿ“ Winston-Salem Wake Forest University Health Sciences Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) NCT07284641Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Hematopoietic stem cell transplant (HSCT) Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation NCT06807606Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Drugs Cyclophosphamide, Fludarabine, Thiotepa, Tacrolimus, Mycophenolate mofetil Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia NCT06155188NA1 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: applying of FLU+CY post-HSCT Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors NCT00785525Phase 34 sites๐Ÿ“ Boca Raton๐Ÿ“ Rockville๐Ÿ“ Minneapolis Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: Filgrastim A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203) NCT06615050Phase 330 sites๐Ÿ“ Palo Alto๐Ÿ“ San Francisco๐Ÿ“ Miami Incyte Corporation ยท Tests: Tacrolimus (Tac), Methotrexate (MTX), Ruxolitinib (Rux), Cyclophosphamide, Mycophenolate mofetil (MMF) CIBMTR Research Database NCT01166009n/a2 sites๐Ÿ“ Minneapolis๐Ÿ“ Milwaukee Center for International Blood and Marrow Transplant Researโ€ฆ Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning NCT06815003Phase 21 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyโ€ฆ A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation NCT06859424Phase 213 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Palo Alto Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: Conditioning Regimen A, Conditioning Regimen B, Conditioning Regimen C, Conditioning Regimen D, Conditioning Regimen E Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study NCT06650553NA1 site๐Ÿ“ Taiyuan Shanxi Bethune Hospital ยท Tests: Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT โ€ฆ Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy NCT07347990NA1 site๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: iptacopan Mozobil for Autologous Hematopoietic Stem Cell Transplantation NCT07188090Phase 21 site๐Ÿ“ Philadelphia Thomas Jefferson University ยท Tests: Plerixafor, Gcsf
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy